文献速递炎症性肠病

宿主遗传与肠道菌群相互作用对炎症性肠病发病及临床表现的影响

Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
PubMed 文献 · Gut · 2016-10-08

研究对313例炎症性肠病患者和582名真正健康对照进行病例对照分析,评估肠道菌群组成与11个功能遗传变异构建的遗传风险评分。结果显示,健康对照中炎症性肠病遗传风险评分越高,罗斯氏菌属(Roseburia)越少(错误发现率0.017);结肠型克罗恩病与回肠型克罗恩病患者的肠道菌群不同,回肠型与α多样性降低相关(p=3.28×10-13)。

要点

  • 健康对照中,炎症性肠病遗传风险评分与罗斯氏菌属减少显著相关(错误发现率0.017)。
  • 疾病部位是肠道菌群的主要决定因素:结肠型与回肠型克罗恩病患者的菌群不同。
  • 回肠型克罗恩病与α多样性降低相关(p=3.28×10-13)。

核心结论

  • 首次表明与炎症性肠病相关的遗传风险变异可影响健康个体的肠道菌群。
  • 罗斯氏菌属(Roseburia spp)为乙酸转化为丁酸的细菌,在炎症性肠病患者中已观察到其减少。

研究设计与样本

  • 病例对照分析,纳入313例炎症性肠病患者和582名真正健康对照,对照选自人群队列。
  • 收集粪便样本、外周血和详细表型数据,采用16S rRNA基因标签测序评估肠道菌群组成,并对所有参与者进行基因分型。
  • 从NOD2、CARD9、ATG16L1、IRGM和FUT2基因的11个已证实与炎症性肠病相关的功能遗传变异构建遗传风险评分。

主要发现

  • 健康对照中,炎症性肠病遗传风险评分与罗斯氏菌属减少显著相关(错误发现率0.017)。
  • 疾病部位是肠道菌群的主要决定因素:结肠型克罗恩病患者的肠道菌群与回肠型克罗恩病患者不同。
  • 回肠型克罗恩病与α多样性降低相关(p=3.28×10-13)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with IBD display substantial heterogeneity in clinical characteristics. We hypothesise that individual differences in the complex interaction of the host genome and the gut microbiota can explain the onset and the heterogeneous presentation of IBD. Therefore, we performed a case-control analysis of the gut microbiota, the host genome and the clinical phenotypes of IBD. DESIGN: Stool samples, peripheral blood and extensive phenotype data were collected from 313 patients with IBD and 582 truly healthy controls, selected from a population cohort. The gut microbiota composition was assessed by tag-sequencing the 16S rRNA gene. All participants were genotyped. We composed genetic risk scores from 11 functional genetic variants proven to be associated with IBD in genes that are directly involved in the bacterial handling in the gut: NOD2, CARD9, ATG16L1, IRGM and FUT2. RESULTS: Strikingly, we observed significant alterations of the gut microbiota of healthy individuals with a high genetic risk for IBD: the IBD genetic risk score was significantly associated with a decrease in the genus Roseburia in healthy controls (false discovery rate 0.017). Moreover, disease location was a major determinant of the gut microbiota: the gut microbiota of patients with colonic Crohn's disease (CD) is different from that of patients with ileal CD, with a decrease in alpha diversity associated to ileal disease (p=3.28×10-13). CONCLUSIONS: We show for the first time that genetic risk variants associated with IBD influence the gut microbiota in healthy individuals. Roseburia spp are acetate-to-butyrate converters, and a decrease has already been observed in patients with IBD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Imhann F, Vich Vila A, Bonder MJ, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2016. PMID: 27802154. doi:10.1136/gutjnl-2016-312135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。